The gut microbiota plays a critical role in maintaining digestive health, immune regulation, and protection against harmful microorganisms. While antibiotics are essential for treating bacterial infections, their use can disrupt the natural balance of gut microorganisms, reducing microbial diversity and weakening intestinal defense mechanisms. This imbalance may increase susceptibility to gastrointestinal disturbances, inflammation, and various long-term health complications. Restoring microbial balance has become an important consideration in gastrointestinal care. Saccharomyces boulardii has been studied for its ability to support gut microbial health, help maintain intestinal integrity, reduce the risk of antibiotic-associated diarrhea, and improve symptoms and quality of life in individuals with irritable bowel syndrome.[1][2]
Imbalance of Gut Microbiota: Antibiotics and Its Impact, Clinical Implications of Considering S. boulardii to Overcome AAD and IBS
|
Dr. Swadip Mishra
|
0 Views
Recent Videos
Exploring the Advantage of Including Saccharomyces Boulardii CNCM I-745 in Managing AAD: A Promise to Practice
|
Dr. Milind kadam
|
445 Views
Clinical Application of Saccharomyces boulardii CNCM I-745 in Various Patient Profiles
|
Dr. Bhaskar Kante
|
0 Views
Emerging Evidences on Clinical Application of Saccharomyces boulardii CNCM I-745
|
Dr. P Bharath Kumar Reddy
|
0 Views
Evidence for Optimal Therapy in Managing IBS
|
Dr. Brundaban Nahak
|
422 Views
Evidence for Optimal Therapy in Managing IBS
|
Dr. Arvind Kumar Sharma
|
450 Views
Evidence for Optimal Therapy in Managing IBS
|
Dr. Sachin Dhande
|
477 Views
Evidence for Optimal Therapy in Managing IBS
|
Dr. Nitin Gothwal
|
426 Views
Exploring the Advantage of Including Saccharomyces boulardii CNCM I-745 in Managing AAD: A Promise to Practice
|
Dr. Md Naushad Alam
|
513 Views